Letter: Metabolic Dysfunction-Associated Steatotic Liver Disease in Primary Biliary Cholangitis—Friend, Foe or Red Herring? Authors' Reply

IF 6.6 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Alimentary Pharmacology & Therapeutics Pub Date : 2024-10-09 DOI:10.1111/apt.18332

Conrado Fernández, Antonio Olveira

引用次数: 0

Abstract

Click on the article title to read more.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

信原发性胆汁性胆管炎的代谢功能障碍相关性脂肪性肝病--朋友、敌人还是红鲱鱼？作者回复

点击文章标题阅读更多内容。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Alimentary Pharmacology & Therapeutics 医学-胃肠肝病学

CiteScore

15.60

自引率

7.90%

发文量

527

审稿时长

3-6 weeks

期刊介绍： Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.

期刊最新文献

Development and Validation of a PIVKA-II-Based Model for HCC Risk Stratification in Patients With HCV-Related Cirrhosis Successfully Treated With DAA Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease? Editorial: Updated COVID-19 Boosters-Tailoring Protection for Patients With IBD. Authors' Reply. Review Article: Green Management of IBD-New Paradigms for an Eco-Friendly Approach. Subcutaneous Infliximab Concentration Thresholds for Mucosal and Transmural Healing in Patients With Crohn's Disease.